NCT01652859View on ClinicalTrials.gov

An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Normal Healthy Subjects
Interventions
DRUG

Liposomal Amphotericin B

DRUG

AmBisome

Sponsors
All Listed Sponsors
lead

Taiwan Liposome Company

INDUSTRY